BNTC

Benitec Biopharma Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 4/10
  • Value↑ 5/10
Benitec Biopharma sales and earnings growth
BNTC Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -37.50%
  • FCF Y/Y↑ 15.94%
Benitec Biopharma gross and profit margin trends
BNTC Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 1772.10%
Benitec Biopharma net debt vs free cash flow
BNTC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -23.9

Benitec Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗